May 1, 2013
Synthetic Biology Research Community Grows Significantly
Update to synthetic biology map identifies new activity across the globe
The number of private and public entities conducting research in synthetic biology worldwide grew significantly between 2009 and 2013, according to the latest version of an interactive map produced by the Synthetic Biology Project at the Woodrow Wilson International Center for Scholars.
"Part of this new activity has been driven by continuing government investments in the science," said David Rejeski, who directs the Synthetic Biology Project. "Another important factor has been the rapidly declining costs of gene sequencing, which has supported more effective approaches to engineering biological systems."
The Synthetic Biology Project found that the number of companies conducting synthetic biology research increased three-fold since 2009. A plurality of the companies involved in synthetic biology is focusing on developing bio-based specialty chemicals, fuels and/or medicines.
Since 2009, the industry has also experienced moderate levels of consolidation and failure. Of the 61 companies included on the initial 2009 inventory, six were acquired by other companies, closed their doors or can longer be identified. An additional 11 companies that were tracked between the release of the 2009 inventory and the 2013 update were also acquired, closed or cannot be identified.
In addition to the expanded listings, the updated map features improved functionality, more detailed information and additional categories and subcategories. The updated map can also be accessed on Android and Apple mobile devices.
The map can be found here: http://www.synbioproject.org/map
The 2013 analysis can be found here: http://www.synbioproject.org/process/assets/files/6302/_draft/findings_2013.pdf
The map will be updated periodically. Users can submit additional entries to the map using this online form: http://www.synbioproject.org/sbmap/add-item/
On the Net: